Biphasic Response to Dobutamine Predicts Improvement of Global Left Ventricular Function After Surgical Revascularization in Patients With Stable Coronary Artery Disease Implications of Time Course of Recovery on Diagnostic Accuracy by Cornel, Jan H et al.
Biphasic Response to Dobutamine Predicts Improvement of
Global Left Ventricular Function After Surgical Revascularization in
Patients With Stable Coronary Artery Disease
Implications of Time Course of Recovery on Diagnostic Accuracy
JAN H. CORNEL, MD, JEROEN J. BAX, MD,* ABDOU ELHENDY, MD,†
ALEXANDER P. W. M. MAAT, MD,† GEERT-JAN P. KIMMAN, MD,† MARCEL L. GELEIJNSE, MD,†
RICARDO RAMBALDI, MD,† ERIC BOERSMA, MSC,† PAOLO M. FIORETTI, MD‡
Alkmaar, Leiden and Rotterdam, The Netherlands and Udine, Italy
Objectives. This study sought to evaluate the time course of
improvement of left ventricular (LV) dysfunction in stable pa-
tients and its implications on the accuracy of dobutamine echo-
cardiography for predicting improvement after surgical revascu-
larization.
Background. Little is known about the optimal timing for
evaluation of postrevascularization recovery of the contractile
function of viable myocardium.
Methods. Sixty-one patients with chronic ischemic LV dysfunc-
tion scheduled for elective surgical revascularization were pro-
spectively selected. They underwent dobutamine echocardiogra-
phy (5 to 40 mg/kg body weight per min) and radionuclide
ventriculography both preoperatively and at 3-month follow-up.
At 14 months, another evaluation of LV function was obtained. To
analyze echocardiograms, a 16-segment model and a five-point
scoring system were used. Dyssynergic segments were considered
likely to recover in the presence of a biphasic contractile response
to dobutamine. Improvement of global function was defined as a
>25% increase in LV ejection fraction (LVEF).
Results. Of the 61 patients, LVEF improved in 12 at 3 months
and in 19 at late follow-up (from 32 6 8% to 42 6 9%, p < 0.0001).
The frequency and time course of improvement of LVEF were
similar in patients with mild and severe LV dysfunction. A
biphasic response, identified in 186 of the 537 dyssynergic seg-
ments, was predictive of recovery in 63% at 3 months and in 75%
at late follow-up. The positive predictive value was best in the
most severe dyssynergic segments (90% vs. 67%). Other responses
were highly predictive for nonrecovery (92%). The sensitivity and
specificity for improvement of global function on a patient basis
(>24 biphasic segments) were 89% and 81%, respectively, at late
follow-up.
Conclusions. Serial postoperative follow-up studies demon-
strate incomplete recovery of contractile function at 3 months.
The diagnostic accuracy of dobutamine echocardiography for
predicting recovery is dependent on three factors: the combining
of low and high dobutamine dosages, the severity of regional
dyssynergy and the timing of evaluation.
(J Am Coll Cardiol 1998;31:1002–10)
©1998 by the American College of Cardiology
Coronary artery bypass graft surgery (CABG) can improve
symptoms, prognosis and left ventricular (LV) function in
selected patients (1). The noninvasive identification of myo-
cardial regions with a high and low probability of functional
improvement after revascularization is crucial to the decision
to perform revascularization procedures in individual patients
with multiple, severe wall motion abnormalities (2). Because
the presence of viable myocardium favorably influences prog-
nosis after revascularization (3–6), these procedures may even
serve as an attractive alternative to heart transplantation.
The contractile response of dyssynergic regions to “low
dose” dobutamine in conjunction with echocardiography has
been proposed as a simple method for the assessment of
residual viable myocardium capable of recovering its contrac-
tile function, both spontaneously in patients early after myo-
cardial infarction (7–11) and after revascularization in patients
with stable, chronic ischemic heart disease (12–20). Recent
data suggest that jeopardized myocardium—a combination of
myocardial viability and inducible ischemia—is more likely to
recover after revascularization than viable myocardium that is
not in jeopardy (16). However, all previous studies using
dobutamine echocardiography have been limited by the lack of
an independent method to verify changes in ventricular func-
tion (12–20).
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The accuracy of predicting recovery of contractile function
after revascularization may depend on several factors, such as
the response to dobutamine both at low and high doses (16)
and the severity of baseline segmental dysfunction (11,15).
Furthermore, it is unclear what the optimal timing is, to
evaluate recovery of contractile function after revasculariza-
tion. Given the severity of structural changes observed in
hibernating myocardium (21–23), it is likely that recovery of
function after revascularization is delayed for several months.
Therefore, we designed a prospective study to evaluate 1)
the accuracy of dobutamine echocardiography to predict re-
covery of regional and global LV dysfunction after successful
CABG in patients with a wide range of chronic LV dysfunc-
tion; and 2) the time course of functional improvement after
CABG using both serial echocardiographic and radionuclide
ventriculographic studies, thus defining the optimal timing to
determine the diagnostic value of dobutamine echocardiogra-
phy in this clinical setting.
Methods
Patient enrollment. From January 1993 to April 1995, all
patients with coronary artery disease and LV dysfunction at
rest who were scheduled to undergo CABG at the Thorax-
center were screened for enrollment in the study. The study
protocol was approved by the Institutional Review Board.
Inclusion criteria included symptoms of stable coronary artery
disease, previous acceptance for elective surgical revascular-
ization, LV ejection fraction (LVEF) ,50% on contrast
ventriculography and one or more abnormal contractile seg-
ments on the preoperative (,3 weeks before operation) rest
echocardiogram (16-segment left ventricular [LV] model).
Furthermore, a subsequent uneventful surgical revasculariza-
tion procedure was required to proceed with the protocol.
Exclusion criteria included unstable angina, recent myocardial
infarction (,3 months), significant (.50%) left main stem
stenosis, (hemodynamically) significant valvular disease, poor
echocardiographic quality or the inability to obtain written,
informed consent. Of the 89 preoperative, eligible patients, 28
were excluded. The reasons for exclusion were resection of
infarcted areas in addition to myocardial revascularization in
13 patients, perioperative death in 6 (7%), perioperative
nonfatal myocardial infarction in 2, poor echocardiographic
quality in 3, inability to obtain written, informed consent in 2,
death on the waiting list for the operation in 1 and death early
in the follow-up period (at 10 weeks) in 1. Of the patients who
died perioperatively, two deaths were due to pump failure and
four were due to perioperative myocardial infarction. Of the 61
patients finally included in the present study, 5 (8%) under-
went CABG as an alternative to heart transplantation.
Study protocol. Each patient underwent low and high dose
dobutamine stress echocardiography and radionuclide ven-
triculography within 3 weeks before the operation. All patients
underwent uneventful, isolated CABG (by definition). The
decision to revascularize was based on clinical criteria. The
results of the dobutamine stress echocardiographic and radio-
nuclide studies were withheld from the physicians managing
the patients. Adequate revascularization of a dyssynergic seg-
ment was considered achieved if, on review of the operative
report and preoperative coronary arteriogram, bypass grafts
were placed on the stenotic major branches supplying the
dyssynergic segments. After the operation, patients were fol-
lowed up to a maximum of 19 months. At the 3-month
follow-up visit, both rest and low and high dose dobutamine
stress echocardiography and rest radionuclide ventriculogra-
phy were repeated. At 14-month follow-up, two-dimensional
rest echocardiography and radionuclide ventriculography (for
the third time) were performed.
Dobutamine stress echocardiography. Before the test, pa-
tients were asked to discontinue beta-blockers for 36 h. All
other cardiac medications (e.g., calcium antagonists, nitrates
and angiotensin-converting enzyme inhibitors) were contin-
ued. The dobutamine stress test was performed as follows: a
two-dimensional transthoracic echocardiogram in standard
views and a 12-lead electrocardiogram (ECG) were recorded
with the patient at rest. Dobutamine was infused through an
antecubital vein at dosages of 5 and 10 mg/kg body weight per
min for 5 min at each dose (these two steps were considered as
“low dose”). Subsequently, three other steps from 20 to
40 mg/kg per min (3 min each) were added. Finally, atropine
(up to 1 mg) was injected when 85% of the predicted maximal
(men [220 2 age] 3 85%, women [200 2 age] 3 85%) heart
rate had not been reached (24). A three-lead ECG was
monitored continuously, and a 12-lead ECG was recorded
every minute. Cuff blood pressure was measured at each stage.
The test was interrupted prematurely if 85% of the predicted
maximal heart rate was reached or if severe chest pain, ST
segment deviation .2 mm, significant ventricular or supraven-
tricular arrhythmia, systolic blood pressure fall .40 mm Hg or
any other intolerable side effect occurred during the test.
The echocardiogram was monitored throughout the test,
and the last minute of each stage, including recovery, was
recorded on videotape. The echocardiographic images were
also digitized on optical disk (Vingmed CFM 800) or on floppy
disk (Esaote Biomedica SIM 7000) and displayed side by side
in quad screen format to facilitate the comparison of images at
rest and at various stages of the test.
Analysis of echocardiograms. The interpretation of echo-
cardiograms was done by two experienced observers who had
no knowledge of the clinical, radionuclide, angiographic and
previous echocardiographic results of the individual patients.
In case of disagreement, a third observer reviewed the study
and a majority decision was attained. The assessment was
Abbreviations and Acronyms
CABG 5 coronary artery bypass graft surgery
CI 5 confidence interval
ECG 5 electrocardiogram, electrocardiographic
LV 5 left ventricular
LVEF 5 left ventricular ejection fraction
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based on both the digitized images displayed in a quad screen
format and a review of the images recorded on the videotape.
For analysis of wall motion, the left ventricle was divided into
16 segments, as recommended by the American Society of
Echocardiography (25). The wall motion, including wall thick-
ening, of each segment was semiquantitated using a five-point
scoring system: 1 5 normal wall motion and thickening; 2 5
mildly hypokinetic; 3 5 severely hypokinetic; 4 5 akinetic; and
5 5 dyskinetic. We defined a segment as severely hypokinetic
in the presence of minimal wall thickening with very limited
inward motion (during the first half of systole); as akinetic in
the absence of systolic wall motion and thickening, confirmed
by M-mode echocardiographic tracing whenever possible; and
as dyskinetic in the presence of systolic outward motion with
thinning. Wall thickening was primarily utilized for the classi-
fication of wall motion, preventing the problem of postopera-
tive paradoxic septal motion. Also, to reduce the confounding
effect of tethering from adjacent segments, segmental wall
thickening was analyzed only during the first half of systole.
During dobutamine infusion, abnormally contracting seg-
ments at rest were classified into four different patterns of
contractile response: biphasic, defined as improvement at low
dose and worsening at peak stress; sustained improvement,
defined as improvement at low dose without further deterio-
ration at peak stress; worsening, defined as direct worsening
with no improvement at any stage; and no change, defined as
unchanged wall motion abnormality throughout the test.
We previously reported a low level of interobserver and
intraobserver variability for the classification of rest wall
motion (agreement 84% and 87%, respectively) and the re-
sponse to low dose dobutamine (agreement 92% and 94%,
respectively) in a comparable patient group (15).
Myocardial ischemia was judged to be present when there
was worsening of the segmental score by $1 (in normally
contracting segments or dyssynergic segments showing wors-
ening or a biphasic response). As previously reported, ischemia
was not considered when akinetic segments at baseline became
dyskinetic at stress without improvement during low dose
dobutamine infusion (26).
Follow-up echocardiograms were compared with the corre-
spondent preoperative rest images. The observers had no
knowledge of the preoperative dobutamine results. For each
segment, functional postoperative recovery was defined as a
decrease of one or more grades. A change from dyskinetic to
akinetic was not considered to be improved contractile func-
tion.
Radionuclide ventriculography. Equilibrium radionuclide
ventriculography was performed at rest with the patient in the
supine position after intravenous administration of 555 MBq of
technetium-99m. Images were acquired with a small field of
view gamma camera (Orbiter, Siemens Corp.) oriented in the
45° left anterior oblique position with a 5° to 10° caudal tilt.
The LVEF was calculated by an automated technique. Im-
provement of global LV function after revascularization was
defined as an increase in LVEF by at least five points (e.g.,
from 30% to 35%). This cutoff was chosen because it is higher
than 2 SD of the interobserver and intraobserver variability of
the measurements of the radionuclide LVEF in our laboratory.
Statistical analysis. Age, number of stenotic coronary ar-
teries, LVEF, heart rate and systolic blood pressure are
expressed as the mean value 6 SD. Differences within contin-
uous variables over time were evaluated by analysis of variance
for repeated measures or by the paired Student t test when
appropriate. Stepwise logistic regression models were fitted to
identify independent predictors of improvement of LVEF 14
months after revascularization; the variables tested were age,
gender, previous CABG, previous infarction, diabetes mellitus,
hypertension, vessel disease, presence of collateral circulation,
LVEF before revascularization, preoperative medication and
response during dobutamine infusion. Significance for all tests
was set at p 5 0.05. Sensitivity, specificity and positive and
negative predictive values rely on the standard definition and
are reported with the 95% confidence intervals (CI).
Results
Patients. A total of 61 patients were included in the study
(mean age 61 years [range 43 to 77], 49 men and 12 women).
All patients were symptomatic, 57 had angina pectoris (29 in
New York Heart Association functional class II, 28 in class III)
and 29 had dyspnea on effort (26 in functional class II, 3 in
class III). Fifty-nine patients had a history of myocardial
infarction (median 24 months before study [range 4 to 210]).
The mean number of significantly stenosed coronary arteries
was 2.7 6 0.5, and the mean LVEF was 33% (range 17% to
49%). The baseline characteristics of the study group, stratified
into two groups according to LVEF (.35% vs. #35%), are
summarized in Table 1. Medication taken by patients before
versus after revascularization included angiotensin-converting
enzyme inhibitors in 40 versus 40 patients, respectively, beta-
adrenergic blocking agents in 44 versus 41, nitrates in 50 versus
10, calcium antagonists in 41 versus 20 and diuretic agents in 18
versus 20.
Baseline characteristics. Of a total of 976 myocardial
segments, 19 were not adequately visualized by echocardiog-
raphy and 28 were not revascularized. Therefore, 929 segments
were available for serial analysis. Abnormal rest wall motion
was seen in 537 segments (58%). Mild hypokinesia was ob-
served in 240 segments; 82 segments were severely hypokinetic;
205 were akinetic; and 10 were dyskinetic.
Clinical and functional postoperative outcome. Three
months after revascularization, only 3 patients had angina
pectoris and 13 had dyspnea on effort (all in functional class
II). At late follow-up (median 14 months [range 11 to 19]), two
patients suffered from angina pectoris and 14 had dyspnea on
effort (all in functional class II).
At 3 months, 136 (25%) of the 537 dyssynergic and revas-
cularized segments showed recovery of wall motion at rest, as
assessed with rest echocardiography. Recovery was observed in
67 of 240 mildly hypokinetic, 35 of 82 severely hypokinetic, 32
of 205 akinetic and 2 of 10 dyskinetic segments. At late
follow-up, an additional 33 segments (25 mildly hypokinetic, 4
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severely hypokinetic and 4 akinetic segments) showed recovery
of contractile function, resulting in a total of 169 segments
(31%) that showed recovery of contractile function late after
revascularization. Furthermore, eight severely hypokinetic or
akinetic segments, already recovered at 3 months, showed
further improvement at late follow-up. Thus, functional recov-
ery was found more frequently in mildly or severely hypoki-
netic than in akinetic/dyskinetic segments (41% vs. 19%, p ,
0.001). The timing of recovery was not delayed in segments
showing the most severe wall motion abnormalities. At 3
months, recovery was already complete in 81% of the severely
hypokinetic or akinetic/dyskinetic segments, compared with
73% of the mildly hypokinetic segments. Deterioration of rest
wall motion was noted in 8 (29%) of the 28 nonrevascularized
dyssynergic segments, in 35 (7%) of the 537 revascularized
dyssynergic segments at 3 months and in 47 (9%) of the 537 at
late follow-up. Of these 47 segments, 29 were ischemic during
dobutamine infusion before revascularization.
At 3 months, 12 patients showed a $5% improvement in
LVEF. At late follow-up, an additional seven patients im-
proved, resulting in a total of 19 with improvement (Fig. 1).
Thirteen of these patients had a preoperative LVEF #35%.
Figure 1 depicts the functional outcome in patients stratified
according to LVEF. It appears that frequency and time course
of improvement of LVEF are similar in patients with mild and
severe LV dysfunction. Figure 2 shows the magnitude and time
course of improvement of global LV function in the individual
19 patients with improvement at late follow-up. The LVEF
increased from 32 6 8% to 37 6 12% at 3 months and to 42 6
9% at late follow-up (p , 0.0001). For the entire study group,
LVEF did not change significantly (from 33 6 8% to 35 6
10%).
Results of dobutamine stress echocardiography. No seri-
ous complications occurred during the test. Heart rate in-
creased from 71 6 13 beats/min at rest to 136 6 14 beats/min
at peak stress (p , 0.0001). Systolic blood pressure did not
change significantly (127 6 18 mm Hg at rest to 125 6
22 mm Hg at peak stress). Heart rate but not systolic blood
pressure increased significantly with low dose dobutamine,
compared with baseline values (83 6 19 beats/min and 126 6
20 mm Hg, respectively). Five patients were taking beta-
blockers during the preoperative dobutamine stress test. Forty-
five patients received the maximal 40-mg/kg per min dose of
dobutamine. Atropine was administered to 28 patients. Angina
occurred in 40 patients (66%), and ST segment deviation in 40
patients (66%). The reasons for termination of the test were
angina (n 5 39), attainment of .85% maximal heart rate (n 5
20) with or without signs of myocardial ischemia, wall motion
abnormalities (n 5 1) and hypotension (n 5 1).
Myocardial ischemia was demonstrated in 343 (37%) of 929
segments: in 100 normally contracting, 159 mildly hypokinetic,
53 severely hypokinetic and 31 akinetic segments. Myocardial
ischemia was detected in 60 patients, with a mean of 5.9
segments per patient. Inducible myocardial ischemia de-
Figure 2. Graph showing the time course of improvement of LVEF
after CABG in the 19 patients who significantly improved at late
follow-up. The mean LVEF increased from 32 6 8% to 37 6 12% at
3 months and to 42 6 9% at late follow-up (p , 0.0001).







Age (yr) 61 6 8 60 6 9
Hypertension 10 (45%) 9 (23%)
Diabetes mellitus 4 (18%) 7 (18%)
Previous CABG 3 (14%) 3 (8%)
Old MI 21 38
Q wave/non–Q wave MI 14/7 33/5
Angina pectoris 20 (91%) 37 (95%)
Effort dyspnea 5 (23%) 24 (62%)
Coronary arteriography 22 39
3-vessel disease 14 (64%) 29 (74%)
2-vessel disease 7 (32%) 9 (23%)
1-vessel disease 1 (5%) 1 (3%)
LVEF (%) 41 6 4 28 6 5
Dyssynergic segments 151 (45%) 386 (65%)
Mild hypokinesia 78 162
Severe hypokinesia 9 73
Akinesia/dyskinesia 64 151
Biphasic response 55 131
Data presented are number (%) of patients or segments or mean value 6
SD. CABG 5 coronary artery bypass graft surgery; F 5 female; LVEF 5 left
ventricular ejection fraction; M 5 male; MI 5 myocardial infarction.
Figure 1. Diagram demonstrating the frequency and timing of post-
operative improvement of LVEF of $5% in patients with a preoper-
ative LVEF #35% versus .35%. NO IMPR 5 no improvement; INT
IMPR 5 improvement at 3 months; NEW LATE IMPR 5 late
improvement between 3 months and 1 year.
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creased significantly after the operation from 343 to 20 seg-
ments (p , 0.0001, $2 segments in five patients).
Of a total of 537 revascularized segments with abnormal
wall motion, 186 (35%) segments exhibited a biphasic re-
sponse, 58 (11%) demonstrated sustained improvement, 68
(12%) showed worsening (without improvement), and 225
(42%) showed no change in regional wall motion during
dobutamine challenge.
Predictive accuracy of dobutamine stress echocardiography
for functional recovery. The different types of response to
dobutamine infusion in relation to the functional outcome of
all dyssynergic segments after revascularization at 3 months
and at late follow-up are depicted in Figure 3.
At 3 months, 118 (63%) of 186 segments with a biphasic
response showed recovery of wall motion, whereas the other
three patterns were not predictive of functional recovery. At
late follow-up, 140 (75%) of 186 segments with a biphasic
response showed recovery of wall motion. Also, segments with
sustained improvement showed a trend toward recovery at late
follow-up (22%). When considering only the low dose phase, a
positive inotropic response (n 5 244) showed a positive
predictive value of 63% for recovery at late follow-up. This
underscores the added value of the biphasic pattern in predict-
ing functional recovery. Assuming a biphasic response as
indicative of recovery and the other three predefined patterns
as indicative of no recovery, the sensitivity, specificity and
positive and negative predictive values for functional recovery
are 87% (95% CI 81% to 93%), 83% (95% CI 79% to 87%),
63% (95% CI 56% to 70%) and 95% (95% CI 93% to 97%) at
3-month follow-up and 83% (95% CI 77% to 89%), 88% (95%
CI 85% to 91%), 75% (95% CI 69% to 81%) and 92% (95%
CI 89% to 95%), at late follow-up, respectively.
Figure 4 shows the influence of severity of segmental LV
dysfunction at baseline on the predictive value of dobutamine
echocardiography and the timing of the follow-up study. It
clearly demonstrates a much less accurate prediction of func-
tional recovery in mildly hypokinetic segments compared with
severely hypokinetic/akinetic segments. In addition, it shows
that the positive predictive value improves when late follow-up
is considered (mild hypokinesia: 67% [95% CI 59% to 75%] vs.
53% [95% CI 44% to 62%]; severe hypokinesia/akinesia: 90%
[95% CI 83% to 97%] vs. 81% [95% CI 72% to 90%]). At late
follow-up, both the specificity (74% [95% CI 67% to 81%] vs.
97% [95% CI 95% to 99%]) and positive predictive value (67%
[95% CI 59% to 75%] vs. 90% [95% CI 83% to 97%]) were
significantly better in segments with the most severe wall
motion abnormalities at baseline. In contrast, neither the
sensitivity (86% [95% CI 79% to 93%] vs. 79% [95% CI 70%
to 88%]) nor negative predictive value (89% [95% CI 84% to
94%] vs. 93% [95% CI 90% to 96%]) differed significantly
Figure 3. Bar graph demonstrating prediction of recovery of regional
ventricular function 3 months (A) and 14 months (B) after surgical
revascularization related to the different types of responsiveness to
dobutamine infusion preoperatively. Solid bars 5 recovery (%);
hatched bars 5 no recovery (%).
Figure 4. Bar graph demonstrating prediction of recovery of regional
ventricular function 3 months (A) and 14 months (B) after surgical
revascularization, related to the preoperative degree of wall motion
abnormality and different types of responsiveness to dobutamine
infusion. SH/AK1 5 severely hypokinetic or akinetic segments with a
biphasic response; SH/AK2 5 severely hypokinetic or akinetic seg-
ments without a biphasic response, including sustained improvement;
H1 5 mildly hypokinetic segments with a biphasic response; H2 5
mildly hypokinetic segments without a biphasic response. Symbols as in
Figure 3.
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between mildly hypokinetic and severely hypokinetic/akinetic
segments.
To provide more insight into the relation between the
number of segments showing a biphasic response per patient
and the magnitude of change in LVEF at late follow-up, linear
regression analysis was performed (Fig. 5). It showed that most
patients (17 of 25) with four or more jeopardized but viable
segments had improved global LV function after revascular-
ization (r 5 0.61).
The sensitivity and specificity for the detection of functional
improvement of global LV function ($5% increase of LVEF)
at late follow-up were determined in all patients and in two
subsets with either somewhat preserved or diminished LV
function (Table 2). In patients with #35% LVEF, the diagnos-
tic accuracy of the test seems similar compared with that in the
patients with mild LV dysfunction (positive predictive value
63% vs. 71%; negative predictive value 93% vs. 95%).
Univariate analysis identified the preoperative use of beta-
blockers and a global biphasic response during dobutamine
infusion as the only predictors of improvement of LVEF at late
follow-up. Multivariate analysis showed that a global biphasic
response was the only independent predictor.
Discussion
Few studies have addressed the time course of recovery of
contractile function of chronically dysfunctional myocardium
after successful revascularization (27,28). In the present study,
we have tried to evaluate potential factors that may influence
the diagnostic accuracy of dobutamine stress echocardiography
in predicting the effects of revascularization on contractile
function in patients with chronic ischemic LV dysfunction.
Radionuclide ventriculography was used to verify changes in
global LV function. The main findings are as follows:
1. In one-third of our patients, as well as in the subset with
#35% LVEF, global LV function significantly improved
after revascularization. Serial postoperative follow-up stud-
ies demonstrated gradual improvement with incomplete
improvement at 3 months. The frequency and time course
of improvement of LVEF were similar in patients with mild
and severe LV dysfunction.
2. This study confirms that a biphasic response to dobutamine
is highly predictive of postoperative recovery of regional
contractile function (75% at late follow-up). The other
patterns of dobutamine responsiveness are predictors of
nonrecovery (92% at late follow-up). The diagnostic accu-
racy of dobutamine responsiveness is best in segments with
the most severe wall motion abnormalities at baseline,
reaching sensitivity, specificity and positive and negative
predictive values of 79%, 97%, 90% and 93%, respectively.
3. Dobutamine stress echocardiography in the aforemen-
tioned clinical setting, including segments with mild dys-
function, has a sensitivity of 89% and a specificity of 81% to
predict a $5% improvement in LVEF.
All previous studies using dobutamine echocardiography
have also used echocardiography to assess recovery of wall
motion, without an independent technique to verify these data
(12–20,29). In the present study, we have circumvented this
shortcoming by using serial radionuclide ventriculographic
studies for the assessment of changes in global LV function.
Our study is unique in that it reports the effects of sequential
follow-up studies on the diagnostic accuracy of the test for
postrevascularization improvement of both regional and global
LV function. Furthermore, this study adds to the accumulating
evidence that high dose dobutamine stress testing, even with
the addition of atropine, can be performed safely without
serious complications in patients with poor LV function (30).
Timing of follow-up. The optimal timing for the assessment
of functional recovery after revascularization is essential for
the correct interpretation of the diagnostic accuracy of a given
test. Currently, functional follow-up studies in chronic coro-
nary artery disease are performed within 3 months after the
revascularization procedure (12,14–20,29,31). In individual
patients all types of reversible and irreversible contractile
dysfunction may coexist, including repetitive myocardial stun-
ning and hibernation. However, chronic ischemic myocardium
does not represent a uniform morphologic appearance, but
varies from slight changes to severe ultrastructural damage
(23). In addition, the degree of damage does not correlate with
the severity of the wall motion abnormalities (23). Nonethe-
less, myocardium with severe ultrastructural changes (21,22) is
Figure 5. Postoperative change in LVEF at late follow-up, related to
the number (Nr) of segments with a biphasic response in 61 patients.
Table 2. Sensitivity and Specificity for the Presence of Four or More
Segments With a Biphasic Response on the Preoperative
Dobutamine Echocardiogram to Predict $5% Improvement in Left
Ventricular Ejection Fraction Late After Revascularization
Sensitivity Specificity
All pts (n 5 61) 89% (17/19) 81% (34/42)
Pts with LVEF #35%
(n 5 39)
92% (12/13) 81% (21/26)
Pts with LVEF .35%
(n 5 22)
83% (5/6) 81% (13/16)
LVEF 5 left ventricular ejection fraction; Pts 5 patients.
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likely to show delayed recovery of contractile function after
revascularization. Therefore, because a time dependence of
structural remodeling is likely, recovery may appear gradually
(28), and its completion should not be expected before 4 to 8
months after revascularization in patients with chronic coro-
nary artery disease. Our data support these concepts, because
7 of the 19 patients with improvement at late follow-up did not
show improvement of global LV function at 3 months. Such
delayed improvement after CABG has been described earlier
(27,28,32) and underlines the importance of late follow-up
studies after revascularization procedures in this clinical set-
ting.
A similar time course of improvement of LVEF was found
in patients with mild and severe LV dysfunction. This is not
surprising, because it has been reported that the severity of LV
dysfunction is not correlated with the degree of ultrastructural
damage (23).
Biphasic response. Several studies, experimental or clini-
cal, using a head to head comparison between dobutamine
stress echocardiography and myocardial perfusion scintigra-
phy, describe a relation between a biphasic response to dobut-
amine and myocardial scintigraphic ischemia (33–35). This
relation can be explained by the presence of viable tissue in a
dyssynergic segment subtended by a critically stenotic coronary
artery, exhibiting an inotropic response to low dose dobut-
amine and ischemia at high dose dobutamine provoked by the
increased rate–pressure product and flow maldistribution. In
the present study, the majority of segments demonstrating such
a biphasic response recovered in contractile function after
revascularization. Our findings are in accordance with data
reported by Afridi et al. (16). Reversible, chronic ischemic LV
dysfunction is associated with ultrastructural alterations, in-
cluding minimal fibrosis, loss of myofilaments and an accumu-
lation of intracellular glycogen (21,23,36). These morphologic
changes have been correlated with recruitable inotropic re-
serve, perfusion–metabolism mismatch and nearly normal ab-
solute myocardial blood flow in combination with reduced
coronary flow reserve (36,37). Repetitive stunning as an alter-
native to myocardial hibernation has been postulated to ex-
plain these findings. It is likely that after successful revascular-
ization, high energy phosphate stores are ensured through
adequate myocardial perfusion at rest and during stress. Under
these circumstances, by rebuilding cellular contractile material,
dyssynergic myocardium may recover over time.
Other responses to dobutamine challenge. In dyssynergic
segments demonstrating a sustained improvement during do-
butamine, it is likely that there is sufficient coronary flow and
metabolic reserve to maintain enhanced contractility until the
final stage of the test. Functional recovery after revasculariza-
tion was demonstrated in 22% of these segments. The presence
of myocardial stunning without substantial subendocardial
fibrosis in segments showing functional recovery could explain
the findings. The remaining segments, which did not demon-
strate functional recovery, may have contained a mixture of
predominantly normal, nonjeopardized myocardium and sub-
endocardial necrosis leading to wall motion abnormalities at
rest with preserved inotropic reserve (31). Segments with
direct worsening in wall motion during dobutamine challenge
rarely recovered after revascularization. It is conceivable that
these segments contain a mixture of a considerable amount of
scar tissue and some normal myocardium, becoming ischemic
during dobutamine infusion. Although Afridi et al. (16) re-
ported a higher recovery rate of these segments (35%), one
should bear in mind that in absolute terms this represents only
six segments. Finally, the lack of change in wall thickening
during dobutamine infusion is a very specific marker for the
prediction of a lack of functional recovery after surgical
revascularization. This echocardiographic pattern of not re-
sponding to dobutamine is therefore in agreement with the
diagnosis of scar with no clinically relevant amount of residual
viable myocardium. This observation is quite relevant, because
it suggests that further tests for the assessment of the potential
reversibility of dysfunction in segments with this specific echo-
cardiographic pattern are redundant.
Diagnostic accuracy. Previous studies using low dose do-
butamine echocardiography have concentrated on the predic-
tion of regional recovery after revascularization. They show
sensitivities ranging from 71% to 97% (weighted mean 85%)
and specificities ranging from 63% to 95% (weighted mean
89%) (12,14–20). Our results add to the accumulating evi-
dence that the test is an accurate method for the evaluation of
myocardial viability in patients with chronic dysfunctional
myocardium due to coronary artery disease. In our study, both
the specificity and positive predictive value improved when
only severely dyssynergic segments were evaluated, similar to
previous studies (14,15,18,31). Mildly hypokinetic segments
are likely to contain normal myocardium, subendocardial scar
or viable but dysfunctional myocardium, or a combination of
these. If relatively little viable tissue is present, hypokinesia is
caused by the presence of subendocardial scar, and then
dobutamine challenge may stimulate normal myocardium to a
hyperkinetic response, simulating a positive test for viability. In
contrast, if a substantial amount of viable myocardium is
present (without substantial scar tissue), a similar test result
may appear. However, only in the latter example should one
expect functional recovery to occur after revascularization.
False positive tests occur less often in severe dyskinesia,
because the presence of normal myocardial tissue is minimal in
segments with severe contractile dysfunction.
In the present study we showed that patients with four or
more jeopardized but viable segments (25% of the myocar-
dium) are likely to have improved global LV function. The
data confirm earlier studies (17,38–42) employing different
techniques to assess myocardial viability, and indicate that a
substantial amount of viable but jeopardized myocardium
needs to be present to result in improved global LV function.
This observation implies, if confirmed in larger series, that
dobutamine stress echocardiography is a reliable technique to
predict functional outcome after revascularization, even in
patients with poor LV function.
Study limitations. Incomplete revascularization may pro-
hibit viable segments to recover, thereby underestimating the
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diagnostic accuracy of a diagnostic technique. Because we did
not perform repeat angiography after the operation to assess
graft patency, we do not know about the success of coronary
revascularization. However, repeat dobutamine stress echocar-
diographic studies performed 3 months after CABG revealed a
decrease in inducible myocardial ischemia from 343 to 20
segments. Because we did not study patients at 6 months, we
do not know about the completeness of improvement at 6
months. Therefore, we cannot comment on this issue regarding
the optimal timing of follow-up studies for the detection of
complete recovery of contractile function after CABG in the
aforementioned clinical setting. Detailed and larger studies are
needed to answer this question.
Regional wall thickness has not been measured. Normal
end-diastolic thickness has been described as marker of myo-
cardial viability and a predictor of recovery after revascular-
ization (43,44). In contrast, dyssynergic segments with severely
reduced thickness rarely show recovery of contractile function
after revascularization. Further studies are needed to answer
the question of what is the additional value of dobutamine
challenge on top of wall thickness measurements. In addition,
LV volumes may provide important prognostic information
(45). Unfortunately, these variables were not assessed in the
current study.
Patients with poor LV function may potentially benefit
most from myocardial viability studies, given the condition that
viability leads to improvement of global LV function. Because
only a small number of patients with poor LV function were
studied, we cannot draw firm conclusions about the diagnostic
accuracy of dobutamine stress echocardiography for the pre-
diction of functional improvement in these patients.
Conclusions. Serial postoperative follow-up studies dem-
onstrate incomplete recovery of contractile function at 3
months. Dobutamine stress echocardiography is a useful
method to predict improvement of regional and global LV
function after CABG. Its diagnostic accuracy depends on 1)
combining low and high doses of dobutamine infusion; 2) the
severity of regional dyssynergy; and 3) the timing of evaluation.
This study contributes to the increasing clinical experience with
dobutamine stress echocardiography in patients with stable
ischemic LV dysfunction.
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